US2017203106A1PendingUtilityA1
Directly integrated feedthrough for an implantable medical device housing using a gold alloy
Assignee: HERAEUS DEUTSCHLAND GMBH & CO KGPriority: Dec 12, 2013Filed: Mar 29, 2017Published: Jul 20, 2017
Est. expiryDec 12, 2033(~7.4 yrs left)· nominal 20-yr term from priority
C22C 5/02B23K 35/28B23K 35/3013B23K 35/0255B23K 35/007B23K 35/383C21D 9/50B23K 35/30B23K 1/008B23K 1/0008A61N 1/3754B23K 35/0222B23K 2103/14B23K 35/0244B23K 35/38B23K 1/0016B23K 1/20B23K 2101/36B23K 2201/36
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
One aspect provides an implantable medical device with a titanium housing having a flange defining a recess about an opening through the housing. The opening is disposed within the recess. A feedthrough is disposed within the recess with a gap between an insulator of the feedthrough and the flange. A braze joint is between the insulator and the flange that occupies the gap and hermetically seals the insulator to the housing. The braze joint includes a biocompatible gold alloy having a melting point less than the β-transus temperature of the titanium of the housing.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . An implantable medical device comprising:
a titanium housing with a flange defining a recess about an opening through the housing, the opening disposed within the recess; a feedthrough disposed within the recess with a gap between an insulator of the feedthrough and the flange; and a braze joint between the insulator and the flange that occupies the gap and hermetically seals the insulator to the housing, the braze joint comprising a biocompatible gold alloy having a melting point less than the β-transus temperature of the titanium of the housing; wherein the gap has a distance in the range of 10-50 μm in order to optimize capillary action of the biocompatible gold alloy of the braze joint.
2 . The implantable medical device of claim 1 , wherein a surface of the insulator to which the braze joint is bonded includes a metalized layer.
3 . The implantable medical device of claim 1 characterized in that insulator of the feedthrough is coupled directly to the housing without an intervening ferrule or other structure.
4 . The implantable medical device of claim 1 , wherein the gold alloy consists of gold and germanium.
5 . The implantable medical device of claim 1 , wherein the gold alloy consists of gold and indium.
6 . The implantable medical device of claim 1 , wherein the gold alloy consists of gold, silver, platinum, copper, and zinc.
7 . The implantable medical device of claim 1 , wherein the melting point of the gold alloy does not exceed 870° C.
8 . The implantable medical device of claim 1 , wherein the melting point of the gold alloy does not exceed 710° C.
9 . The implantable medical device of claim 1 , wherein the melting point of the gold alloy does not exceed 487° C.
10 . The implantable medical device of claim 1 , wherein the melting point of the gold alloy does not exceed 361° C.
11 . The implantable medical device of claim 1 , wherein the titanium of the housing within 0.25 inches of the opening has a grain size not exceeding 100 μm.
12 . An implantable medical device comprising:
a titanium housing with a flange defining a recess about an opening through the housing, the opening disposed within the recess; a feedthrough disposed within the recess with a gap between an insulator of the feedthrough and the flange; and a braze joint between the insulator and the flange that occupies the gap and hermetically seals the insulator to the housing, the braze joint comprising a biocompatible gold alloy having a melting point less than the β-transus temperature of the titanium of the housing.
13 . The implantable medical device of claim 12 , wherein the gap has a distance in the range of 10-50 μm in order to optimize capillary action of the braze.
14 . The implantable medical device of claim 12 , wherein a surface of the insulator to which the braze joint is bonded includes a metalized layer.
15 . The implantable medical device of claim 12 , wherein the gold alloy consists of gold and germanium.
16 . The implantable medical device of claim 12 , wherein the gold alloy consists of gold and indium.
17 . The implantable medical device of claim 12 , wherein the gold alloy consists of gold, silver, platinum, copper, and zinc.
18 . The implantable medical device of claim 12 , wherein the melting point of the gold alloy does not exceed 870° C.
19 . The implantable medical device of claim 12 , wherein the melting point of the gold alloy does not exceed 361° C.
20 . The implantable medical device of claim 12 , wherein the titanium of the housing within 0.25 inches of the opening has a grain size not exceeding 100 μm.Join the waitlist — get patent alerts
Track US2017203106A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.